Results 211 to 220 of about 177,759 (342)

Marécages, une pollution par essence? Conditions d'une écopoétique des marais et autres zones humides au XXe siècle

open access: yesOrbis Litterarum, Volume 81, Issue 3, Page 271-280, June 2026.
Abstract To expose the pollution of marshes and swamps, whether by hydrocarbons or other contaminants, the French or Francophone author of the twentieth century must first confront a literary tradition that equates stagnant water with a volatile poison and, more broadly, wetlands with toxic environments. In his article “Wetland Gloom and Wetland Glory,”
François Sagot
wiley   +1 more source

Duel energy CT imaging of tophaceous gout.

open access: green, 2013
Lindsey Fitzgerald   +3 more
openalex   +1 more source

Accuracy of Diagnostic Codes and Algorithms Used to Identify Rheumatoid Arthritis and Juvenile Idiopathic Arthritis in Administrative Claims and Electronic Health Records: Systematic Review and Meta‐Analysis

open access: yesArthritis Care &Research, Volume 78, Issue 5, Page 670-682, May 2026.
Objective This systematic review aimed to assess the diagnostic accuracy of algorithms used to identify rheumatoid arthritis and juvenile idiopathic arthritis in electronic health records. Methods We searched Medline, Embase, and Cochrane Central Register for Controlled Trials databases and included studies that validated case definitions against a ...
Constanza Saka‐Herrán   +10 more
wiley   +1 more source

Chronic tophaceous gout – A case report

open access: diamond, 2023
A. Lakshmi   +4 more
openalex   +2 more sources

Use of Semaglutide and Tirzepatide in Rheumatic and Musculoskeletal Diseases: Insights on Initiation Patterns and Weight Loss From the Rheumatology Informatics System for Effectiveness Registry

open access: yesACR Open Rheumatology, Volume 8, Issue 5, May 2026.
Objective Glucagon‐like peptide‐1 receptor agonists (GLP‐1 RAs) such as semaglutide (SEM) and tirzepatide (TZP) were initially approved for type 2 diabetes management but are increasingly used for weight loss. Limited data exist on real‐world use among patients with rheumatic and musculoskeletal diseases (RMDs).
Nicholas P. McCormick   +7 more
wiley   +1 more source

Sirt3 Genetically Engineered Apoptotic Bodies Alleviate Skeletal Aging by Limiting Aggravated NLRP3 Inflammasome Activation of Senescent Macrophages

open access: yesAdvanced Science, Volume 13, Issue 26, 8 May 2026.
The senescence of macrophages leads to a decrease in the expression of Sirtuin3 (Sirt3), which in turn aggravates the NLRP3 inflammasome activation and IL‐1β secretion, thereby promoting the aging‐related osteoporosis. Sirt3‐enriched apoptotic bodies (ABs‐Sirt3) generated through genetic editing approaches can alleviate skeletal aging by targeting ...
Yanglin Wu   +7 more
wiley   +1 more source

Home - About - Disclaimer - Privacy